Journal of Drug Assessment
Volume 7, 2018 - Issue 1
Open access
523
Views
0
CrossRef citations to date
0
Altmetric
Infectious Disease
A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers
Stephen YoungbergCelerion, Lincoln, NE, USA;
, Erin BrandtCelerion, Lincoln, NE, USA;
, Avantika BarveNovartis Institutes for BioMedical Research, East Hanover, NJ, USA;
, Surendra MachineniNovartis Healthcare Private Limited, Hyderabad, India;
, Christopher T. JonesNovartis Institutes for BioMedical Research, Emeryville, CA, USA;
, Kristina DabovicNovartis Institutes for BioMedical Research, East Hanover, NJ, USA;
, Catherine L. JonesNovartis Institutes for BioMedical Research, Emeryville, CA, USA;
& Richard A. ColvinNovartis Institutes for BioMedical Research, Cambridge, MA, USACorrespondence[email protected]
show all
Pages 66-74
|
Received 15 Jun 2018, Accepted 09 Oct 2018, Published online: 24 Oct 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.